Standout Papers
- BCL-2, BCL-XL Sequester BH3 Domain-Only Molecules Preventing BAX- and BAK-Mediated Mitochondrial Apoptosis (2001)
- Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics (2002)
- tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c (2000)
- A Distinct Pathway Remodels Mitochondrial Cristae and Mobilizes Cytochrome c during Apoptosis (2002)
- Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c (2000)
Immediate Impact
9 by Nobel laureates 42 from Science/Nature 184 standout
Citing Papers
Ponsegromab for the Treatment of Cancer Cachexia
2024 Standout
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
Works of Solly Weiler being referenced
MAP3K11/GDF15 axis is a critical driver of cancer cachexia
2015
BCL-2, BCL-XL Sequester BH3 Domain-Only Molecules Preventing BAX- and BAK-Mediated Mitochondrial Apoptosis
2001 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Solly Weiler | 5582 | 613 | 955 | 931 | 37 | 6.8k | |
| Natalia Shpiro | 4265 | 417 | 952 | 747 | 36 | 5.7k | |
| Beni B. Wolf | 5231 | 450 | 1309 | 1200 | 52 | 7.5k | |
| Peng Li | 5706 | 322 | 1045 | 1377 | 40 | 7.8k | |
| Sylvie Montessuit | 5859 | 420 | 676 | 854 | 38 | 6.9k | |
| Paola Costantini | 6250 | 497 | 851 | 928 | 53 | 8.2k | |
| Hans Kristian Lorenzo | 4451 | 331 | 761 | 835 | 33 | 5.9k | |
| Estela Jacinto | 6842 | 679 | 895 | 1448 | 45 | 8.7k | |
| Peter M. Finan | 5141 | 878 | 1133 | 1436 | 40 | 7.5k | |
| William Landschulz | 5604 | 791 | 879 | 1018 | 33 | 8.5k | |
| Jean‐Claude Chambard | 4606 | 751 | 1185 | 874 | 52 | 7.3k |
All Works
Loading papers...